Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2025 16:04 ET | Source: NurExone Biologic Inc

NurExone Advances Vision Restoration Strategy with Preclinical Data Presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2025

TORONTO and HAIFA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company...
April 24, 2025 16:15 ET | Source: NurExone Biologic Inc

NurExone to Showcase Breakthrough in Facial Nerve Regeneration at ISEV 2025

NurExone's Exosome-Based ExoPTEN Targets Three High-Value Nerve Injury Indications